Mitterer Manfred, Lanthaler Andrea J, Irschick Eveline U, Engelmann Hartmut, Larcher Clara, Huemer Hartwig P
Department of Transfusion Medicine, Meran Hospital, Meran, Italy.
Leuk Res. 2005 Dec;29(12):1479-88. doi: 10.1016/j.leukres.2005.05.007. Epub 2005 Jun 24.
The T-cell population of a patient with persistent polyclonal B-cell lymphocytosis (PPBL) presenting with an intermittent Epstein-Barr virus (EBV)-associated disease was studied. Unstimulated T-cells did not express CD40 ligand (CD40L), whereas activation with IL-2 led to expression of this costimulatory molecule. CD40L expression was inhibited upon incubation with the supernatant of an EBV-positive B-cell line (SM) which had been grown spontaneously from the patient's peripheral blood cells. The supernatant of SM cells effectively inhibited cytotoxic T-cells. Elevated levels of IL-10, TNF-alpha and soluble CD40 were found in the supernatant of SM cells. Additionally, enhanced levels of LMP-1 protein were detected.